Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenomatous Polyps | 1 | 2018 | 8 | 0.570 |
Why?
|
| Jejunal Neoplasms | 1 | 2018 | 6 | 0.570 |
Why?
|
| Lower Gastrointestinal Tract | 1 | 2018 | 3 | 0.150 |
Why?
|
| Pelvis | 1 | 2018 | 64 | 0.140 |
Why?
|
| Faculty, Medical | 1 | 2017 | 77 | 0.130 |
Why?
|
| Sacrococcygeal Region | 1 | 2015 | 6 | 0.120 |
Why?
|
| Students, Medical | 1 | 2017 | 132 | 0.120 |
Why?
|
| Oophoritis | 1 | 2015 | 1 | 0.120 |
Why?
|
| Sigmoid Diseases | 1 | 2015 | 4 | 0.120 |
Why?
|
| Xanthomatosis | 1 | 2015 | 3 | 0.120 |
Why?
|
| Intestinal Obstruction | 1 | 2015 | 12 | 0.110 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2006 | 71 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2017 | 338 | 0.110 |
Why?
|
| Colonic Neoplasms | 2 | 2006 | 74 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 947 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 1307 | 0.100 |
Why?
|
| Middle Aged | 5 | 2018 | 12125 | 0.090 |
Why?
|
| Female | 7 | 2018 | 20261 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2009 | 29 | 0.080 |
Why?
|
| Intestines | 1 | 2009 | 60 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2009 | 70 | 0.080 |
Why?
|
| Humans | 10 | 2018 | 32798 | 0.080 |
Why?
|
| Neoplasms | 1 | 2015 | 761 | 0.070 |
Why?
|
| Adenocarcinoma | 2 | 2006 | 300 | 0.060 |
Why?
|
| Rectal Neoplasms | 1 | 2005 | 21 | 0.060 |
Why?
|
| Adult | 5 | 2018 | 9560 | 0.050 |
Why?
|
| Colonic Pouches | 1 | 2003 | 9 | 0.050 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2003 | 6 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2003 | 57 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2003 | 24 | 0.050 |
Why?
|
| Stomach Neoplasms | 1 | 2003 | 113 | 0.050 |
Why?
|
| Male | 6 | 2018 | 19641 | 0.040 |
Why?
|
| Reference Values | 1 | 2018 | 238 | 0.040 |
Why?
|
| Time Management | 1 | 2017 | 9 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2017 | 120 | 0.030 |
Why?
|
| Aged | 4 | 2018 | 10538 | 0.030 |
Why?
|
| Communication | 1 | 2017 | 141 | 0.030 |
Why?
|
| Intrauterine Devices | 1 | 2015 | 3 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2015 | 19 | 0.030 |
Why?
|
| Rosaniline Dyes | 2 | 2006 | 18 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 56 | 0.030 |
Why?
|
| Lymph Node Excision | 2 | 2006 | 95 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 412 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2017 | 324 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 576 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 894 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1572 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2015 | 3701 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1238 | 0.020 |
Why?
|
| North Carolina | 1 | 2015 | 1546 | 0.020 |
Why?
|
| Smoking | 1 | 2015 | 531 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2284 | 0.020 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2006 | 8 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2006 | 20 | 0.020 |
Why?
|
| Keratins | 1 | 2006 | 37 | 0.020 |
Why?
|
| Colectomy | 1 | 2006 | 30 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2006 | 30 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 47 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2006 | 169 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2006 | 308 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 470 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2005 | 80 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2006 | 565 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 292 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2005 | 205 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 486 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2003 | 43 | 0.010 |
Why?
|
| Anal Canal | 1 | 2003 | 20 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 563 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 908 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 887 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 4032 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 3438 | 0.010 |
Why?
|